Exhibit 107.1
CALCULATION OF FILING FEE TABLES
Form S-8
Registration Statement Under
The Securities Act Of 1933
(Form Type)
Reata Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
|
Table 1 – Newly Registered Securities |
|||||||
|
Security Type |
Security Class Title |
Fee Calculation Rule (2) |
Amount Registered (1) |
Proposed Maximum Offering Price Per Unit (2) |
Maximum Aggregate Offering Price (2) |
Fee Rate |
Amount of registration fee (3) |
|
Equity |
Class A common stock, par value $0.001 per share |
Other |
1,601,487 |
$51,407,733 |
$92.70 per $1,000,000 |
$4,765.50 |
|
|
Equity |
Class B common stock, par value $0.001 per share |
Other |
1,601,487 |
$32.10 |
$51,407,733 |
$92.70 per $1,000,000 |
$0 |
|
Total Offering Amounts |
|
|
|
$4,765.50 |
|||
|
Total Fee Offsets |
|
|
|
— |
|||
|
Net Fee Due |
|
|
|
$4,765.50 |
|||
|
(2) |
Estimated solely for purposes of calculating the registration fee in accordance with Rule 457(h) under the Securities Act. The price for the Class A common stock and Class B common stock being registered hereby is based on a price of $32.10 |
|
per share of Class A common stock, which is the average of the high and low trading prices for a share of Class A common stock of the Registrant as reported on the NASDAQ Global Market on March 14, 2022. |
|
(3) |
Pursuant to General Instruction E to Form S-8, a registration fee is only being paid with respect to the registration of an additional 1,601,487 aggregate shares of either Class A common stock or Class B common stock under the Plan. |